<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01106820</url>
  </required_header>
  <id_info>
    <org_study_id>BEATE-1</org_study_id>
    <nct_id>NCT01106820</nct_id>
  </id_info>
  <brief_title>Progressive Resistance Training Versus Relaxation for Breast Cancer Patients During Chemotherapy: Biological Mechanisms and Effects on Fatigue and Quality of Life</brief_title>
  <acronym>BEATE</acronym>
  <official_title>Progressive Resistance Training vs. Relaxation for Breast Cancer Patients During Chemotherapy: A Randomized Controlled Intervention Trial to Evaluate the Biological Mechanisms and Effects of Resistance Training on Fatigue and Quality of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>German Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Center for Tumor Diseases, Heidelberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Heidelberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Institute of Mental Health, Mannheim</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>German Cancer Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this randomized intervention study is to investigate the effects and
      biological mechanisms of a supervised 12-week progressive resistance training on fatigue and
      quality of life in breast cancer patients during chemotherapy. To determine the effect of the
      exercise itself beyond potential psychosocial effects due to attention by trainers or the
      group support, patients in the control group have a comparable training schedule (i.e. 60
      min, twice a week, for 12 weeks) but with relaxation training (Jacobsen method).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fatigue measured by Fatigue Assessment Questionnaire (FAQ)</measure>
    <time_frame>change between baseline and week 13 (end of intervention)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life measured by the European Organisation for Research and Treatment of Cancer questionnaire (EORTC-QLQ30/BR23)</measure>
    <time_frame>change between baseline and week 13 (end of intervention)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression measured by &quot;Allgemeine Depressionsskala&quot; (ADS, the German version of the Center for Epidemiological Studies Depression Scale (CES-D))</measure>
    <time_frame>change between baseline and week 13 (end of intervention)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength measured at the IsoMed2000Â®</measure>
    <time_frame>change between baseline and week 13 (end of intervention)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiorespiratory fitness measured by ergospirometry</measure>
    <time_frame>change between baseline and week 13 (end of intervention)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarker in blood, urine, and saliva</measure>
    <time_frame>change between baseline and week 6 and 13</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse events potentially related to the resistance training</measure>
    <time_frame>during the 12-week exercise intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">101</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Cancer-related Fatigue</condition>
  <arm_group>
    <arm_group_label>Resistance training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Relaxation training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Supervised progressive resistance training</intervention_name>
    <description>Supervised progressive resistance training</description>
    <arm_group_label>Resistance training</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Supervised progressive muscle relaxation training (Jacobsen method)</intervention_name>
    <description>Supervised progressive muscle relaxation training (Jacobsen method)</description>
    <arm_group_label>Relaxation training</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  breast cancer patient after lumpectomy or mastectomy, stage I-III

          -  adjuvant chemotherapy

          -  BMI at least 18

        Exclusion Criteria:

          -  contraindication for exercise

          -  radiotherapy during intervention period
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Steindorf, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>NCT Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>German Cancer Research Center</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Schmidt ME, Wiskemann J, Krakowski-Roosen H, Knicker AJ, Habermann N, Schneeweiss A, Ulrich CM, Steindorf K. Progressive resistance versus relaxation training for breast cancer patients during adjuvant chemotherapy: design and rationale of a randomized controlled trial (BEATE study). Contemp Clin Trials. 2013 Jan;34(1):117-25. doi: 10.1016/j.cct.2012.10.006. Epub 2012 Oct 25.</citation>
    <PMID>23103936</PMID>
  </reference>
  <results_reference>
    <citation>Schmidt ME, Wiskemann J, Armbrust P, Schneeweiss A, Ulrich CM, Steindorf K. Effects of resistance exercise on fatigue and quality of life in breast cancer patients undergoing adjuvant chemotherapy: A randomized controlled trial. Int J Cancer. 2015 Jul 15;137(2):471-80. doi: 10.1002/ijc.29383. Epub 2014 Dec 16.</citation>
    <PMID>25484317</PMID>
  </results_reference>
  <results_reference>
    <citation>Klassen O, Schmidt ME, Scharhag-Rosenberger F, Sorkin M, Ulrich CM, Schneeweiss A, Potthoff K, Steindorf K, Wiskemann J. Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy. Acta Oncol. 2014 Oct;53(10):1356-65. doi: 10.3109/0284186X.2014.899435. Epub 2014 May 16.</citation>
    <PMID>24837860</PMID>
  </results_reference>
  <results_reference>
    <citation>Scharhag-Rosenberger F, Kuehl R, Klassen O, Schommer K, Schmidt ME, Ulrich CM, Wiskemann J, Steindorf K. Exercise training intensity prescription in breast cancer survivors: validity of current practice and specific recommendations. J Cancer Surviv. 2015 Dec;9(4):612-9. doi: 10.1007/s11764-015-0437-z. Epub 2015 Feb 26.</citation>
    <PMID>25711667</PMID>
  </results_reference>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2010</study_first_submitted>
  <study_first_submitted_qc>April 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2010</study_first_posted>
  <last_update_submitted>December 16, 2016</last_update_submitted>
  <last_update_submitted_qc>December 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

